GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Deferred Policy Acquisition Costs

Acticor Biotech (XPAR:ALACT) Deferred Policy Acquisition Costs


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Acticor Biotech (XPAR:ALACT) Business Description

Industry
Traded in Other Exchanges
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.